Annotated Medicine and Device Lists

Paracetamol

Oral liquid 125 mg/5 mL Oral liquid 100 mg/ml Oral liquid 125mg/5ml or 120mg/5ml Oral liquid 120 mg/5 mL Oral liquid 140 mg/5 ml (3%) Oral liquid 120 mg/5 mL Oral Solution (drops) 100mg/ml Suppository 100 mg Suppository 100-300mg Suppository 250 mg Suppository 125mg (infantile) Suppository 300 mg Tablet 100 mg to 500 mg Tablet 300 mg to 500 mg Tablet 500 mg Tablet 100mg Tablet 500 mg Tablet 80 mg Tablet 325 mg

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	2.1. Non-opioids and non-steroidal anti-inflammatory medicines (NSAIMs)	Others observations: Not recommended for anti-inflammatory use due to lack of proven benefit to that effect.
WHO Model List of Essential Medicines (2021)	7.1. For treatment of acute attack	This medicine is only for children.
Training CSamouge 2022	2.1 Non-opioids and non-steroidal anti-inflammatory medicines (NSAIMs)	Others observations: Not recommended for anti-inflammatory use due to lack of proven benefit to that effect

This medicine is present in:

List	Section	Observation
Colombia	13.2 Non-Narcotic Analgesics	No observations

This medicine is present in:

List	Section	Observation
Bolivia	LINAME 2011 - 2013	No observations

This medicine is present in:

List	Section	Observation
Peru	2.1 Non-Opiate Analgesics and Non-Steroidal Anti-Inflammatories (NSAIDs)	No observations
Peru	7.1 For Treatment of Acute Attacks	No observations
Ecuador	Essential Medicines List - Ecuador	No observations
Cuba	2.1 Analgésicos no opioides	No observations
Cuba	7.1 Tratamiento del ataque agudo	No observations
Training CSamouge 2022	2.1 Non-opioids and non-steroidal anti-inflammatory medicines (NSAIMs)	Others observations: Not recommended for anti-inflammatory use due to lack of proven benefit to that effect
WHO Model List of Essential Medicines (2021)	7.1. For treatment of acute attack	This medicine is only for children.

This medicine is present in:

List	Section	Observation
Colombia	13.2 Non-Narcotic Analgesics	No observations

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	2.1. Non-opioids and non-steroidal anti-inflammatory medicines (NSAIMs)	Others observations: Not recommended for anti-inflammatory use due to lack of proven benefit to that effect.

This medicine is present in:

List	Section	Observation
Bolivia	LINAME 2011 - 2013	No observations
Peru	2.1 Non-Opiate Analgesics and Non-Steroidal Anti-Inflammatories (NSAIDs)	No observations
Ecuador	Essential Medicines List - Ecuador	No observations
Chile	Essential and Prioritized Medications	No observations

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	2.1. Non-opioids and non-steroidal anti-inflammatory medicines (NSAIMs)	Others observations: Not recommended for anti-inflammatory use due to lack of proven benefit to that effect.
Bolivia	LINAME 2011 - 2013	No observations
Training CSamouge 2022	2.1 Non-opioids and non-steroidal anti-inflammatory medicines (NSAIMs)	Others observations: Not recommended for anti-inflammatory use due to lack of proven benefit to that effect

This medicine is present in:

List	Section	Observation
Peru	2.1 Non-Opiate Analgesics and Non-Steroidal Anti-Inflammatories (NSAIDs)	No observations

This medicine is present in:

List	Section	Observation
Ecuador	Essential Medicines List - Ecuador	No observations
Chile	Essential and Prioritized Medications	No observations

This medicine is present in:

List	Section	Observation
Chile	Essential and Prioritized Medications	No observations

This medicine is present in:

List	Section	Observation
Cuba	2.1 Analgésicos no opioides	This medicine is only for children.
Cuba	7.1 Tratamiento del ataque agudo	This medicine is only for children.

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	2.1. Non-opioids and non-steroidal anti-inflammatory medicines (NSAIMs)	Others observations: Not recommended for anti-inflammatory use due to lack of proven benefit to that effect.
Training CSamouge 2022	2.1 Non-opioids and non-steroidal anti-inflammatory medicines (NSAIMs)	Others observations: Not recommended for anti-inflammatory use due to lack of proven benefit to that effect

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	7.1. For treatment of acute attack	No observations

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	2.1. Non-opioids and non-steroidal anti-inflammatory medicines (NSAIMs)	No observations
WHO Model List of Essential Medicines (2021)	7.1. For treatment of acute attack	No observations
Bolivia	LINAME 2011 - 2013	No observations
Peru	2.1 Non-Opiate Analgesics and Non-Steroidal Anti-Inflammatories (NSAIDs)	No observations
Peru	7.1 For Treatment of Acute Attacks	No observations
Cuba	2.1 Analgésicos no opioides	No observations

This medicine is present in:

List	Section	Observation
Bolivia	LINAME 2011 - 2013	No observations
Chile	Essential and Prioritized Medications	No observations

This medicine is present in:

List	Section	Observation
Ecuador	Essential Medicines List - Ecuador	No observations
Chile	Essential and Prioritized Medications	No observations
Colombia	13.2 Non-Narcotic Analgesics	No observations
Cuba	7.1 Tratamiento del ataque agudo	No observations

This medicine is present in:

List	Section	Observation
Chile	Essential and Prioritized Medications	No observations

This medicine is present in:

List	Section	Observation
WHO Model List of Essential Medicines (2021)	2.1. Non-opioids and non-steroidal anti-inflammatory medicines (NSAIMs)	No observations
WHO Model List of Essential Medicines (2021)	7.1. For treatment of acute attack	No observations

Information Resources: Paracetamol

Should ibuprofen or paracetamol be given in infants and children with fever?
Fever in children.